NCT06342427View on ClinicalTrials.gov

Stomach Cancer Exosome-based Detection

CompletedOBSERVATIONAL
Enrollment

809

Participants

Timeline

Start Date

March 15, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

June 15, 2024

Conditions
Gastric CancerGastric AdenocarcinomaGastric Cancer StageGastric NeoplasmGastric LesionGastric Cancer in SituGastric Cancer Stage IVGastric Cancer Stage IIIBGastric Cancer Stage IIIGastric Cancer Stage IBGastric Cancer Stage IAGastric Cancer, Stage 0Gastric Cancer Stage IIIAGastric Cancer Stage IIGastric Cancer TNM StagingGastric Cancer Metastatic to LungGastric Cancer Metastatic to LiverGastric Cancer Stage IGastric Cancer TNM Staging Primary Tumor (T) T2B
Interventions
DIAGNOSTIC_TEST

DESTINEX

A panel of microRNA, whose expression level is tested in serum samples.

Trial Locations (3)

91010

City of Hope Medical Center, Duarte

Unknown

Nagoya University, Nagoya

Mie University, Tsu

All Listed Sponsors
lead

City of Hope Medical Center

OTHER